Apogee Therapeutics Inc DEF 14A Filing for April 10 Details

Apogee Therapeutics Inc (APGI) filed its DEF 14A on April 10, 2023. This filing is part of the company's regulatory requirements, detailing executive compensation, corporate governance, and other shareholder information. This event is significant as it provides insights into the company's operational strategies and governance practices. Shareholders often rely on such filings to make informed decisions regarding their investments in APGI.